VVaccine4/18/2026Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adultsKishor K. Paul·Anthony T. Newall·Sophy T.F. Shih·Richard T. Gray·James G. Wood·Allen L. Nazareno·Stephen Jan·Monica TorresRead at VaccineTagsRespiratory viral infections researchEpidemiology
